Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC).

被引：0
|
作者：
Cheng, Tiewei
Schieber, Timothy J.
Clennon, Anna
Bertken, Katie
Cai, Sunny Shengyuan
Wulff-Burchfield, Elizabeth Marie
Abbasi, Saqib
Parikh, Rahul Atul
Li, Haoran
机构：
[1] Univ Kansas, Med Ctr, Westwood, KS USA
[2] Univ Kansas, Canc Ctr, Westwood, KS USA
[3] Aurora St Lukes Med Ctr, Milwaukee, WI USA
[4] Univ Kansas Hlth Syst, Westwood, KS USA
[5] Univ Kansas, Med Ctr, Kansas City, KS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Advancements in the research of immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma
    Sun, Mengfei
    Yang, Pengjie
    Wang, Weisong
    Yu, Yongjun
    Yang, Dongdong
    Ping, Yaodong
    Zhu, Benben
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05): : 1981 - 1998
  • [32] Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized clinical trials
    Dang, Shoutao
    Zhang, Shurong
    Zhao, Jingyang
    Li, Xinyu
    Li, Wei
    CANCER MEDICINE, 2023, 12 (20): : 20277 - 20286
  • [33] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.
    Araujo, Daniel Vilarim
    Wells, Connor
    Hansen, Aaron Richard
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun Loo
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Dudani, Shaan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Efficacy of Immune Checkpoint Inhibitors in Advanced Esophageal Squamous Cell Carcinoma Patients with Hepatitis B
    Pan, J.
    Pan, Q.
    Wu, S.
    Zhang, Q.
    Xu, Y.
    Li, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E477 - E477
  • [35] Efficacy and Safety of Immune Checkpoint Inhibitor Rechallenge in the Treatment of Esophageal Squamous Cell Cancer
    Zhang, Xiaojing
    Zhang, Jingze
    He, Junyi
    Zhong, Xiao
    Yu, Jinming
    Wang, Linlin
    JOURNAL OF CANCER, 2025, 16 (03): : 943 - 951
  • [36] Efficacy of immune checkpoint inhibitors (ICI) in renal cell carcinoma (RCC) venous tumor thrombus (VTT) shrinkage
    Thouvenin, J.
    Bigot, P.
    Chanza, N. Martinez
    Gaillard, V.
    Cazzato, R.
    Boudier, P.
    Maillet, D.
    Boissier, R.
    Barthelemy, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1216 - S1217
  • [37] Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI).
    Alfieri, Salvatore
    Ferrara, Roberto
    Calareso, Giuseppina
    Cavalieri, Stefano
    Platini, Francesca
    Mancinelli, Moela
    Resteghini, Carlo
    Orlandi, Ester
    Iacovelli, Nicola Alessandro
    Ferella, Letizia
    Piazza, Cesare
    Apollonio, Giulia
    Galbiati, Donata
    Bossi, Paolo
    Bergamini, Cristiana
    Locati, Laura Deborah
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Safety and efficacy of retreatment with immune checkpoint inhibitors (ICIs) in patients with metastatic RCC (mRCC) who have previously received an ICI
    Ravi, Praful
    Bakouny, Ziad
    Flippot, Ronan
    Braun, David A.
    Abou Alaiwi, Sarah
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Kilbridge, Kerry L.
    Choudhury, Atish Dipankar
    Harshman, Lauren Christine
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [39] Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
    Baba, Yoshifumi
    Nomoto, Daichi
    Okadome, Kazuo
    Ishimoto, Takatsugu
    Iwatsuki, Masaaki
    Miyamoto, Yuji
    Yoshida, Naoya
    Baba, Hideo
    CANCER SCIENCE, 2020, 111 (09) : 3132 - 3141
  • [40] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345